Most Recent Articles about Allergan plc.
Patent Office Puts Allergan's Mohawk Deal Out Of Its Misery Feb 24, 2018 - PTAB ruled the St. Regis Mohawk Tribe could not claim sovereign immunity to thwart an IPR for Restasis patents.AGN's IPR defense could be a formality at this point.MYL estimated it could meet FDA guid
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2017 Update Feb 24, 2018 - Glenview Capital Management's 13F portfolio value increased from $17.23B to $18.50B this quarter. The number of positions increased from 56 to 58.Larry Robbins substantially increased Thermo Fisher Sc
Berkshire's 4th Quarter Buy Teva Appears Cheap and Troubled Feb 23, 2018 - Berkshire's 4th Quarter Buy Teva Appears Cheap and Troubled, Stocks: BRK.A,BRK.B,TEVA, Warren Buffett, release date:Feb 23, 2018

Related Companies

Name Exchange Price Mkt Cap
VRTX Vertex Pharmaceuticals Incorporated NASDAQ $165.9 $42.12B
ZTS Zoetis Inc. NYSE $82.79 $40.17B
SHPG Shire plc NASDAQ $127.08 $38.55B
CELG Celgene Corporation NASDAQ $95.61 $71.92B
REGN Regeneron Pharmaceuticals, Inc. NASDAQ $323.86 $34.88B
Sector: Health Care > Industry: Major Pharmaceuticals